| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Qiuying Chen, Jie Min, Haibo Yin, Wenying Xia, Yimin Shen, Ming Sh. Relationship between clinical efficacy and plasma concentration-dose ratio of risperidone in patients with schizophrenia. International clinical psychopharmacology. 2023-08-08. PMID:37551602. |
this study aimed to retrospectively explore the relationship between clinical efficacy and plasma concentration-dose ratio of risperidone (ris) in 252 patients with schizophrenia taking ris orally. |
2023-08-08 |
2023-08-14 |
Not clear |
| Tong Zhao, SuFang Tang, XiaoLei Gao, Juan Li, Ran Hao, HaiZhi Chen, GuangBiao Huan. Association of serum brain-derived neurotrophic factor level and early response to antipsychotic drug in first-episode patients with schizophrenia. International journal of methods in psychiatric research. 2023-07-24. PMID:37485797. |
to investigate the role of brain derived neurotrophic factor (bdnf) in the psychotic symptoms in first-episode patients with schizophrenia and whether bdnf levels were associated with the improvement of psychotic symptoms after risperidone treatment. |
2023-07-24 |
2023-08-14 |
Not clear |
| Megumi Oshima, Tadashi Toyama, Yusuke Nakade, Daichi Yomogida, Takahiro Yuasa, Keisuke Horikoshi, Taichirou Minami, Hisayuki Ogura, Shiori Nakagawa, Taro Miyagawa, Shinji Kitajima, Akinori Hara, Norihiko Sakai, Miho Shimizu, Masashi Mita, Masashi Kinoshita, Mitsutoshi Nakada, Mitsuru Kikuchi, Yasunori Iwata, Takashi Wad. Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study. Clinical therapeutics. 2023-07-24. PMID:37487866. |
association between risperidone use and kidney function decline in patients with schizophrenia: a retrospective cohort study. |
2023-07-24 |
2023-08-14 |
mouse |
| Megumi Oshima, Tadashi Toyama, Yusuke Nakade, Daichi Yomogida, Takahiro Yuasa, Keisuke Horikoshi, Taichirou Minami, Hisayuki Ogura, Shiori Nakagawa, Taro Miyagawa, Shinji Kitajima, Akinori Hara, Norihiko Sakai, Miho Shimizu, Masashi Mita, Masashi Kinoshita, Mitsutoshi Nakada, Mitsuru Kikuchi, Yasunori Iwata, Takashi Wad. Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study. Clinical therapeutics. 2023-07-24. PMID:37487866. |
based on the hypothesis that risperidone would prevent kidney disease progression, this study investigated the association between risperidone use and kidney function decline in patients with schizophrenia. |
2023-07-24 |
2023-08-14 |
mouse |
| Xiaoe Lang, Mei Xue, Xiaocui Zang, Fengchun Wu, Meihong Xiu, Xiangyang Zhan. Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study. Journal of translational medicine. vol 21. issue 1. 2023-07-04. PMID:37403159. |
efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study. |
2023-07-04 |
2023-08-14 |
Not clear |
| Evidence-Based Complementary And Alternative Medicin. Retracted: Efficacy of Risperidone Orally Disintegrating Tablets Combined with Oxazepam in the Treatment of Schizophrenia. Evidence-based complementary and alternative medicine : eCAM. vol 2023. 2023-06-30. PMID:37387975. |
retracted: efficacy of risperidone orally disintegrating tablets combined with oxazepam in the treatment of schizophrenia. |
2023-06-30 |
2023-08-14 |
Not clear |
| Xiaoyi Wang, Quanying Bao, Ruifeng Wang, Tingting Li, Yan Wang, Bin Qin, Qi Li, Diane J Burges. In Vivo Characterization of Perseris and Compositionally Equivalent Formulations. International journal of pharmaceutics. 2023-06-24. PMID:37354927. |
perseris is asubcutaneous extended-release risperidone in situ forming implant (suspension) indicated for the treatment of adult schizophrenia. |
2023-06-24 |
2023-08-14 |
human |
| Boukroute Marouane, Soufyane El Kadiri, Manal Merbouh, Ghizlane El Aidouni, Houssam Bkiyar, Brahim Housn. Acute alithiasic pancreatitis following the use of Risperidone in a young man with schizophrenia: As a rare case report. Radiology case reports. vol 18. issue 7. 2023-06-06. PMID:37275744. |
acute alithiasic pancreatitis following the use of risperidone in a young man with schizophrenia: as a rare case report. |
2023-06-06 |
2023-08-14 |
Not clear |
| Boukroute Marouane, Soufyane El Kadiri, Manal Merbouh, Ghizlane El Aidouni, Houssam Bkiyar, Brahim Housn. Acute alithiasic pancreatitis following the use of Risperidone in a young man with schizophrenia: As a rare case report. Radiology case reports. vol 18. issue 7. 2023-06-06. PMID:37275744. |
here, we report the case of acute pancreatitis developing 2 years after the use of risperidone in a young man with schizophrenia. |
2023-06-06 |
2023-08-14 |
Not clear |
| Xiuli Song, Meihong Xiu, Hanlun Yang, Xingjuan Huang, Fengchun Wu, Xiangyang Zhan. Smoking Affects the Predictive Roles of Antioxidant Enzymes in the Clinical Response to Risperidone in Schizophrenia: A Large-scale Cohort Study. Current neuropharmacology. 2023-05-03. PMID:37132112. |
smoking affects the predictive roles of antioxidant enzymes in the clinical response to risperidone in schizophrenia: a large-scale cohort study. |
2023-05-03 |
2023-08-14 |
Not clear |
| Tianhang Zhou, Chengcheng Pu, Zetao Huang, Tianqi Gao, Enpeng Zhou, Yue Zheng, Dan Zhang, Bingjie Huang, Zhang Cheng, Chuan Shi, Xin Y. Weight changes following treatment with aripiprazole, risperidone and olanzapine: A 12-month study of first-episode schizophrenia patients in China. Asian journal of psychiatry. vol 84. 2023-04-24. PMID:37094459. |
weight changes following treatment with aripiprazole, risperidone and olanzapine: a 12-month study of first-episode schizophrenia patients in china. |
2023-04-24 |
2023-08-14 |
Not clear |
| Tianhang Zhou, Chengcheng Pu, Zetao Huang, Tianqi Gao, Enpeng Zhou, Yue Zheng, Dan Zhang, Bingjie Huang, Zhang Cheng, Chuan Shi, Xin Y. Weight changes following treatment with aripiprazole, risperidone and olanzapine: A 12-month study of first-episode schizophrenia patients in China. Asian journal of psychiatry. vol 84. 2023-04-24. PMID:37094459. |
this study aimed to assess weight changes following antipsychotic treatment in first-episode schizophrenia (fes) patients and make a comparison of aripiprazole, risperidone and olanzapine. |
2023-04-24 |
2023-08-14 |
Not clear |
| Cristina Delgado-Sallent, Thomas Gener, Pau Nebot, Cristina López-Cabezón, M Victoria Pui. Neural substrates of cognitive impairment in a NMDAR hypofunction mouse model of schizophrenia and partial rescue by risperidone. Frontiers in cellular neuroscience. vol 17. 2023-04-17. PMID:37066076. |
neural substrates of cognitive impairment in a nmdar hypofunction mouse model of schizophrenia and partial rescue by risperidone. |
2023-04-17 |
2023-08-14 |
mouse |
| Mingjun Zhao, Bin Qin, Yage Mao, Yang Zhang, Ruisheng Zhao, Aiqin Wang, Hailing Wang, Jianting Zhao, Changhong Wan. Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety. Neuropsychiatric disease and treatment. vol 19. 2023-04-12. PMID:37041857. |
paliperidone palmitate versus risperidone long-acting injectable in patients with schizophrenia: a meta-analysis of efficacy and safety. |
2023-04-12 |
2023-08-14 |
Not clear |
| Mingjun Zhao, Bin Qin, Yage Mao, Yang Zhang, Ruisheng Zhao, Aiqin Wang, Hailing Wang, Jianting Zhao, Changhong Wan. Paliperidone Palmitate versus Risperidone Long-Acting Injectable in Patients with Schizophrenia: A Meta-Analysis of Efficacy and Safety. Neuropsychiatric disease and treatment. vol 19. 2023-04-12. PMID:37041857. |
the aim of this study was to assess the efficacy and safety of paliperidone palmitate (pp) treatment compared with risperidone long-acting injectable (lai) treatments for patients with schizophrenia. |
2023-04-12 |
2023-08-14 |
Not clear |
| Xiaofen Zong, Kai Wu, Lei Li, Jiangbo Zhang, Simeng Ma, Lijun Kang, Nan Zhang, Luxian Lv, Deen Sang, Shenhong Weng, Huafu Chen, Junjie Zheng, Maolin H. Striatum-related spontaneous coactivation patterns predict treatment response on positive symptoms of drug-naive first-episode schizophrenia with risperidone monotherapy. Frontiers in psychiatry. vol 14. 2023-04-03. PMID:37009110. |
striatum-related spontaneous coactivation patterns predict treatment response on positive symptoms of drug-naive first-episode schizophrenia with risperidone monotherapy. |
2023-04-03 |
2023-08-14 |
Not clear |
| Zhiyong Gao, Meihong Xiu, Jiahong Liu, Fengchun Wu, Xiang-Yang Zhan. Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone. Schizophrenia (Heidelberg, Germany). vol 9. issue 1. 2023-03-23. PMID:36949120. |
obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone. |
2023-03-23 |
2023-08-14 |
Not clear |
| Kai Zhang, Shipan Miao, Yitan Yao, Yating Yang, Shengya Shi, Bei Luo, Mengdie Li, Ling Zhang, Huanzhong Li. Efficacy and safety of prophylactic use of benzhexol after risperidone treatment. Heliyon. vol 9. issue 3. 2023-03-17. PMID:36925546. |
to test the effect of prophylactic use of benzhexol in schizophrenia patients after risperidone treatment. |
2023-03-17 |
2023-08-14 |
Not clear |
| Kai Zhang, Shipan Miao, Yitan Yao, Yating Yang, Shengya Shi, Bei Luo, Mengdie Li, Ling Zhang, Huanzhong Li. Efficacy and safety of prophylactic use of benzhexol after risperidone treatment. Heliyon. vol 9. issue 3. 2023-03-17. PMID:36925546. |
prophylactic use of benzhexol reduced extrapyramidal symptom in schizophrenia patients after risperidone treatment and did not affect the antipsychotic action of risperidone. |
2023-03-17 |
2023-08-14 |
Not clear |
| Ana Lokmer, Charanraj Goud Alladi, Réjane Troudet, Delphine Bacq-Daian, Anne Boland-Auge, Violaine Latapie, Jean-François Deleuze, Ravi Philip RajKumar, Deepak Gopal Shewade, Frank Bélivier, Cynthia Marie-Claire, Stéphane Jamai. Risperidone response in patients with schizophrenia drives DNA methylation changes in immune and neuronal systems. Epigenomics. 2023-03-15. PMID:36919681. |
risperidone response in patients with schizophrenia drives dna methylation changes in immune and neuronal systems. |
2023-03-15 |
2023-08-14 |
Not clear |